AROA is based in Auckland, New Zealand, with Distribution, Sales, and Customer Services in the US. The company is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. AROA is at the forefront of understanding how biology, structural form and human factors effect healing and is applying its AROA ECM™ platform technology to unlock regenerative healing for everybody.
Location: United States, California, San Diego
Employees: 51-200
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | Alium Capi... | aliumcap.c... |
| - | Movac | movac.co.n... |
| - | Cure Kids ... | curekidsve... |
Mentions in press and media 7
| Date | Title | Description |
| 21.08.2024 | INTERNATIONAL COLLABORATION AIMS TO COMBAT DIABETES EPIDEMIC IN THE SOUTH PACIFIC | AUCKLAND, New Zealand, Aug. 21, 2024 /PRNewswire/ -- Headquartered in Auckland, New Zealand, Aroa Biosurgery is a global soft tissue reconstruction company which develops and manufactures wound care and surgical products to improve healing ... |
| 19.02.2024 | Aroa Venture Partners launches $50 million fund | ETtech Aroa Venture Partners, a 2020-founded venture capital firm that invested in companies such as Unacademy, Urban Company and Cred, has launched a new fund with a target corpus of Rs 400 crore (about $50 million). Aroa Opportunities Fun... |
| 29.11.2022 | AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS | AUCKLAND, New Zealand, Nov. 29, 2022 /PRNewswire/ -- Today New Zealand based soft-tissue regeneration company Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions,... |
| 25.11.2021 | Aroa Biosurgery : Half Yearly Report H1 FY21 | ASX ANNOUNCEMENT/MEDIA RELEASE 25 November 2021 For personal use only A R O A B I O S U R G E R Y H A L F Y E A R L Y R E P O R T H 1 F Y 2 1 Highlights H1 FY22 product revenue (unaudited) grew 110% on H1 FY21 and 39% on H2 FY21, to NZ$17.2... |
| 25.11.2021 | Aroa Biosurgery : Half Yearly Report Update Amendment | ASX ANNOUNCEMENT/MEDIA RELEASE 25 November 2021 For personal use only A R O A B I O S U R G E R Y H A L F Y E A R L Y R E P O R T U P D A T E A M E N D M E N T Soft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, 'AROA' or the... |
| 27.09.2021 | Nuance fund receives $17m NZGCP commitment | New Zealand Growth Capital Partners (NZGCP) today announced a $17 million commitment by its Elevate Fund to Nuance Connected Capital, a new Auckland and Tauranga-based venture capital fund manager. |
| 22.09.2020 | Elevate invests into $200m Movac Fund 5 |